Humanin structural versatility and interaction with model cerebral cortex membranes

Biochemistry

Volumn 48, Issue 22, 2009, Pages 5026-5033

  Pistolesi, Sara ^a   Rossini, Lara ^a,b   Ferro, Elisa ^a   Basosi, Riccardo ^a   Trabalzini, Lorenza ^a   Pogni, Rebecca ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b Siena Biotech SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BI-LAYER; CEREBRAL CORTEX; CIRCULAR DICHROISM; ELECTRON PARAMAGNETIC RESONANCE; EXPERIMENTAL EVIDENCE; HELIX CONFORMATION; HUMANIN; LOW CONCENTRATIONS; NEURONAL CELL; NEURONAL MEMBRANES; NEUROPROTECTIVE PEPTIDES; NEUROTOXICITY; NMR STUDIES; SHEET STRUCTURE; SPIN LABELING; STRUCTURE AND DYNAMICS; WATER SOLUTIONS;

AMINES; CELL DEATH; DICHROISM; ELECTRON RESONANCE; IONIC STRENGTH; IONIZATION OF LIQUIDS; MEMBRANES; PARAMAGNETIC RESONANCE; PARAMAGNETISM; SPIN DYNAMICS;

CELL MEMBRANES;

HUMANIN; WATER;

ARTICLE; BETA SHEET; BRAIN CORTEX; CELL MEMBRANE FLUIDITY; CIRCULAR DICHROISM; ELECTRON SPIN RESONANCE; NERVE CELL MEMBRANE; NEUROPROTECTION; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN INTERACTION; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; SPIN LABELING; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; CEREBRAL CORTEX; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID BILAYERS; MODELS, NEUROLOGICAL; MOLECULAR SEQUENCE DATA; NEUROPROTECTIVE AGENTS; OSMOLAR CONCENTRATION; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; SPIN LABELS;

EID: 66649125501     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi900187s     Document Type: Article

References (47)

1. Hashimoto, Y., Niikura, T., Tajima, H., Yasukawa, T., Sudo, H., Ito, Y., Kita, Y., Kawasumi, M., Kouyama, K., Doyu, M., Sobue, G., Koide, T., Tsuji, S., Lang, J., Kurokawa, K., and Nishimoto, I. (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proc. Natl. Acad. Sci. U.S.A. 98, 6336-6341.
2. Hashimoto, Y., Ito, Y., Niikura, T., Shao, Z., Hata, M., Oyama, F., and Nishimoto, I. (2001) Mechanisms of neuroprotection by a novel rescue factor humanin from Swedish mutant amyloid precursor protein. Biochem. Biophys. Res. Commun. 283, 460-468.
3. Ikonen, M., Liu, B., Hashimoto, Y., Ma, L., Lee, K.-W-, Niikura, T., Nishimoto, I., and Cohen, P. (2003) Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100, 13042-13047.
4. Nishimoto, I., Matsuoka, M, and Niikura, T. (2004) Unravelling the role of humanin. Trends Mol. Med. 10, 102-105.
5. Harada, M., Habata, Y., Hosoya, M., Nishi, K., Fujii, R., Kobayashi, M., and Hinuma, S. (2004) N-formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun. 324, 255-261.
6. Hashimoto, Y., Suzuki, H., Aiso, S., Niikura, T., Nishimoto, I., and Matsuoka, M. (2005) Involvement of tyrosine kinases and STAT3 in humanin-mediated neuroprotection. Life Sci. 77, 3092-3104. (Pubitemid 41423745)
7. Zou, P., Ding, Y., Sha, Y., Hu, B., and Nie, S. (2003) Humanin peptides block calcium influx of rat hippocampal neurons by altering fibrinogenesis of Aβ1-40. Peptides 24, 679-685. (Pubitemid 36929997)
8. Ying, G., Iribarren, P., Zhou, Y., Gong, W., Zhang, N., Yu, Z.-X., Le, Y., Cui, Y., and Wang, J. M. (2004) Humanin, a newly identified neuroprotective factor, uses the G-protein-coupled formylpeptide receptor-like-1 as a functional receptor. J. Immunol. 172, 7078-7085. (Pubitemid 38669150)
9. Tashima, Y., Oe, R., Lee, S., Sugihara, G., Chambers, E. J., Takahashi, M., and Yamada, T. (2004) The effect of cholesterol and monosialoganglioside (GM1) on the release and aggregation of amyloid β-peptide from liposomes prepared from brain membrane-like lipids. J. Biol. Chem. 279, 17587-17595.
10. Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. G., and Langen, R. (2002) Structural and dynamic features od Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277, 40810-40815.
11. Verdier, Y., and Penke, B. (2004) Binding sites of amyloid β-peptide in cell plasma membrane and implications for Alzheimer's disease. Curr. Protein Pept. Sci. 5, 19-31.
12. Yanagisawa, K., Odaka, A., Suzuki, N., and Ihara, Y. (1995) GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 1, 1062-1066.
13. Choo Smith, L.-P., Garzon-Rodriguez, W., Glabe, C. G., and Surewicz, W. K. (1997) Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272, 22987-22990.
14. Yip, C. M., and McLaurin, J. (2001) Amyloid-β peptide assembly: a critical step in- fibrillogenesis and membrane disruption. Biophys. J. 80, 1359-1371. (Pubitemid 32182160)
15. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., and Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/b amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
16. Niikura, T., Chiba, T., Aiso, S., Matsuoka, M., and Nishimoto, I. (2004) Humanin. After the discovery. Mol. Neurobiol. 30, 327-340.
17. Niikura, T., Tajima, H., and Kita, Y. (2006) Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin. Curr. Neuropharmacol. 4, 139-147.
18. Niikura, T., Hashimoto, Y., Tajima, H., Ishizaka, M., Yamagishi, Y., Kawasumi, M., Nawa, M., Terashita, K., Aiso, S., and Nishimoto, I. (2003) A tripartite motif protein TRIM11 binds and destabilizes Humanin, a neuroprotective peptide against Alzheimer's disease-relevant insults. Eur. J. Neurosci. 17, 1150-1158.
19. Guo, B., Zhai,D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A. C., and Reed, J. C. (2003) Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423, 456-461. (Pubitemid 36626999)
20. Zhai, D., Luciano, F., Zhu, X., Guo, B., Satterthwait, A. C., and Reed, J. C. (2005) Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J. Biol. Chem. 280, 15815-15824.
21. Luciano, F., Zhai, D., Zhu, X., Bailly-Maitre, B., Ricci, J.-E., Satterthwait, A. C., and Reed, J. C. (2005) Cytoprotective peptide humanin binds and inhibits pro-apoptotic Bcl-2/Bax-family protein BimEL. J. Biol. Chem. 280, 15825-15835.
22. Arakawa, T., Niikura, T., Tajima, H., and Kita, Y. (2006) The secondary structure analysis of a potent Ser14Gly analog of antiAlzheimer peptide, humanin, by circular dicroism. J. Pept. Sci. 12, 639-642.
23. Arakawa, T., Kita, Y., and Niikura, T. (2008) A rescue factor for Alzheimer's diseases: discovery, activity, structure and mechanism. Curr. Med. Chem. 15, 2086-2098.
24. Arisaka, F., Niikura, T., Arakawa, T., and Kita, Y. (2008) The structure analysis of humanin analog, AGA(C8R)HNG17, by circular dichroism and sedimentation equilibrium: comparison with the parent molecule. Int. J. Biol. Macromol. 43, 88-93.
25. Benaki, D., Zikos, C., Evangelou, A., Livaniou, E., Vlassi, M., Mikros, E., and Pelecanou, M. (2005) Solution structure of humanin, a peptide against Alzheimer's disease-related neurotoxicity. Biochem. Biophys. Res. Commun. 329, 152-160.
26. Benaki, D., Zikos, C., Evangelou, A., Livaniou, E., Vlassi, M., Mikros, E., and Pelecanou, M. (2006) Solution structure of Ser14Gly-humanin, a potent rescue factor against neuronal cell death in Alzheimer's disease. Biochem. Biophys. Res. Commun. 349, 634-642.
27. Altenbach, C., and Hubbell, W. L. (1988) The aggregation state of spin-labeled mellitin in solution and bound to phospholipid membranes: evidence that membrane-bound mellitin is monomeric. Proteins 3, 230-242. (Pubitemid 18183425)
28. Langen, R., Isas, J. M., Luecke, H., Haigler, H. T., and Hubbell, W. L. (1998) Membrane-mediated assembly of annexin studied by site-directed spin labeling. J. Biol. Chem. 273, 22453-22457.
29. Bates, I. R., Boggs, J. M., Feix, J. B., and Harauz, G. (2003) Membrane-anchoring and charge effects in the interaction of myelin basic protein with lipid bilayers studied by site-directed spin labeling. J. Biol. Chem. 278, 29041-29047.
30. Pistolesi, S., Ferro, E., Santucci, A., Basosi, R., Trabalzini, L., and Pogni, R. (2006) Molecular motion of spin labeled side chains in the C-terminal domain of RGL2 protein: a SDSL-EPR and MD study. Biophys. Chem. 123, 49-57.
31. Mchaourab, H. S., Hyde, J. S., and Feix, J. B. (1993) Aggregation state of spin-labeled cecropin AD in solution. Biochemistry 32, 11895-11902. (Pubitemid 23344715)
32. Mchaourab, H. S., Hyde, J. S., and Feix, J. B. (1994) Binding and state of aggregation of spin-labeled cecropin AD in phospholipid bilayers: effects of surface charge and fatty acyl chain length. Biochemistry 33, 6691-6699. (Pubitemid 24189385)
33. Bhargava, K., and Feix, J. B. (2004) Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study. Biophys. J. 86, 329-336. (Pubitemid 38067460)
34. Pistolesi, S., Pogni, R., and Feix, J. B. (2007) Membrane insertion and bilayer perturbation by antimicrobial peptide CM15. Biophys. J. 93, 1651-1660. (Pubitemid 47403306)
35. Der-Sarkissian, A., Jao, C. C., Chen, J., and Langen, R. (2003) Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling. J. Biol. Chem. 278, 37530-37535.
36. Jayasinghe, S. A., and Langen, R. (2004) Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J. Biol. Chem. 279, 48420-48425.
37. Margittai, M., and Langen, R. (2006) Spin labeling analysis of amyloids and other protein aggregates. Methods Enzymol. 413, 122-139. (Pubitemid 44528688)
38. Chen, M., Margittai, M., Chen, J., and Langen, R. (2007) Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J. Biol. Chem. 282, 24970-24979.
39. Stewart, J. C. (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal. Biochem. 100, 10-14.
40. Choi, J., Zhai, D., Zhou, X., Satterthwait, A., Reed, J. C., and Marassi, F. M. (2007) Mapping the specific cytoprotective interaction of humanin with the pro-apoptotic protein Bid. Chem. Biol. Drug Des. 70, 383-392.
41. Han, X., Holtzman, D. M., and McKeel, D. W.Jr. (2001) Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168-1180. (Pubitemid 32467071)
42. Waschuk, S. A., Elton, E. A., Darabi, A. A., Fraser, P. E., and McLaurin, J. (2001) Cellular membrane composition defines A lipid interactions. J. Biol. Chem. 276, 33561-33568.
43. Yip, C. M., Elton, E. A., Darabie, A. A., Morrison, M. R., and McLaurin, J. (2001) Cholesterol, a modulator of membrane-associated Aβ- fibrillogenesis. J. Mol. Biol. 311, 723-734.
44. Ji, S.-R., Wu, Y., and Sui, S.-F. (2002) Cholesterol is an important factor affecting the membrane insertion of a β-amyloid peptide (Aβ1-40), which may potentially inhibit the fibril formation. J. Biol. Chem. 277, 6273-6279.
45. Ramakrishnan, M., Jensen, P. H., and Marsh, D. (2003) α-Synuclein association with phosphatidylglycerol probed by lipid spin labels. Biochemistry 42, 12919-12926. (Pubitemid 37385823)
46. Ramakrishnan, M., Jensen, P. H., and Marsh, D. (2006) Association of α-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR. Biochemistry 45, 3386-3395. (Pubitemid 43376357)
47. D'Errico, G., D'Ursi, A. M., and Marsh, D. (2008) Interaction of a peptide derived from glycoprotein gp36 of feline immunodeficiency virus and its lipoylated analogue with phospholipid membranes. Biochemistry 47, 5317-5327.